Consequences of Iodine Deficiency and Excess in Pregnancy and Neonatal Outcomes: A Prospective Cohort Study in Rio de Janeiro, Brazil

Thyroid ◽  
2020 ◽  
Vol 30 (12) ◽  
pp. 1792-1801
Author(s):  
Nathalie Silva de Morais ◽  
Débora Ayres Saraiva ◽  
Carolina Corcino ◽  
Tatiana Berbara ◽  
Annie Schtscherbyna ◽  
...  
Keyword(s):  
Cohort Study ◽  
Prospective Cohort Study ◽  
Iodine Deficiency ◽  
Prospective Cohort ◽  
Rio De Janeiro ◽  
Neonatal Outcomes ◽  
In Pregnancy

scholarly journals Vaginal dysbiosis in pregnancy associates with risk of emergency cesarean section: a prospective cohort study

2021 ◽  
Author(s):  
Thor Haahr ◽  
Tine Dalsgaard Clausen ◽  
Jonathan Thorsen ◽  
Morten A. Rasmussen ◽  
Martin S. Mortensen ◽  
...  
Keyword(s):  
Cohort Study ◽  
Cesarean Section ◽  
Prospective Cohort Study ◽  
Prospective Cohort ◽  
Emergency Cesarean Section ◽  
Emergency Cesarean ◽  
In Pregnancy

scholarly journals ‘Elective caesarean section at 38–39 weeks gestation compared to > 39 weeks on neonatal outcomes: a prospective cohort study

2018 ◽  
Vol 18 (1) ◽  
Author(s):  
Reihaneh Pirjani ◽  
Motahareh Afrakhteh ◽  
Mahdi Sepidarkish ◽  
Shahin Nariman ◽  
Mahboobeh Shirazi ◽  
...  
Keyword(s):  
Cohort Study ◽  
Caesarean Section ◽  
Prospective Cohort Study ◽  
Prospective Cohort ◽  
Elective Caesarean Section ◽  
Neonatal Outcomes

Pathways Linking Childhood Physical Abuse to Alcohol Misuse in Adolescent Boys and Girls: A Prospective Cohort Study From Rio de Janeiro, Brazil

2020 ◽  
Vol 81 (3) ◽  
pp. 362-371
Author(s):  
Claudia Leite de Moraes ◽  
Marcela De Freitas Ferreira ◽  
Michael Eduardo Reichenheim ◽  
Aline Gaudard E Silva ◽  
Gloria Valeria da Véiga
Keyword(s):  
Cohort Study ◽  
Physical Abuse ◽  
Prospective Cohort Study ◽  
Prospective Cohort ◽  
Rio De Janeiro ◽  
Alcohol Misuse ◽  
Childhood Physical Abuse ◽  
Adolescent Boys

A(H1N1)v2009: A controlled observational prospective cohort study on vaccine safety in pregnancy

Vaccine ◽  
2012 ◽  
Vol 30 (30) ◽  
pp. 4445-4452 ◽  
Author(s):  
Marc Oppermann ◽  
Juliane Fritzsche ◽  
Corinna Weber-Schoendorfer ◽  
Brigitte Keller-Stanislawski ◽  
Arthur Allignol ◽  
...  
Keyword(s):  
Cohort Study ◽  
Prospective Cohort Study ◽  
Prospective Cohort ◽  
Vaccine Safety ◽  
Observational Prospective Cohort Study ◽  
In Pregnancy

F-17 Clinical outcome of liver damage in pregnancy: experience from a prospective cohort study

2012 ◽  
Vol 44 ◽  
pp. S36-S37
Author(s):  
A. Licata ◽  
R.D. Vitello ◽  
G. Licata ◽  
A. Costantino ◽  
D. Mannino ◽  
...  
Keyword(s):  
Cohort Study ◽  
Clinical Outcome ◽  
Prospective Cohort Study ◽  
Liver Damage ◽  
Prospective Cohort ◽  
In Pregnancy

scholarly journals Serum hepcidin and iron status parameters in pregnant women and the association with adverse maternal and fetal outcomes: a study protocol for a prospective cohort study

BMJ Open ◽  
2019 ◽  
Vol 9 (11) ◽  
pp. e032280
Author(s):  
Gabriela Amstad Bencaiova ◽  
Deborah Ruth Vogt ◽  
Irene Hoesli
Keyword(s):  
Cohort Study ◽  
Pregnant Women ◽  
Prospective Cohort Study ◽  
Prospective Cohort ◽  
Gestational Hypertension ◽  
Smoking Status ◽  
Iron Status ◽  
Neonatal Outcomes ◽  
Control Group ◽  
Serum Hepcidin

IntroductionHepcidin production is normally upregulated by iron stores, and in obesity has been shown to be overexpressed and correlated with low iron status. The increased hepcidin may restrain the iron release from the cells by affecting the expression of ferroportin, which probably associates with the development of diabetes complication. First, we investigate the difference of serum hepcidin and iron parameters between obese and non-obese pregnant women; second, we examine the correlation between serum hepcidin and adverse maternal and neonatal outcomes in pregnant women.Methods and analysisThis is a mono-centre, prospective cohort study with a study (obese) and a control group (non-obese women). In the first trimester, 188 singleton pregnancies will be recruited. Thereof, we expect 75 with a body mass index (BMI) ≥30 kg/m2and 113 with a BMI 18.5–30 kg/m2. Serum hepcidin, iron and haematological parameters will be measured at 11–14, 24–28, 32–36 weeks of gestation and at time of delivery. Blood pressure, weight, BMI and smoking status will be examined at all visits. We will assess the composite endpoints adverse maternal outcomes (including pre-eclampsia, gestational hypertension, gestational diabetes mellitus, haemorrhage, placenta abruption) and adverse neonatal outcomes (preterm birth, intrauterine growth restriction, preterm premature rupture of membranes, Apgar score <7 at 5 min, stillbirth, neonatal death).Recruitment has started in April 2019.Ethics and disseminationThis study received ethical approval from the ethics committee in Basel. The results of the study will be published in a peer-reviewed journal, and presented at national scientific conferences.Trial registration numberNCT03792464.

Sign in / Sign up

Export Citation Format

Share Document